Integrative Symptom–Herb Correlation Map
All ingredients in Salva Cell™ are non-toxic and well researched.
Strong — oncology RCT/meta
Moderate — human data/systematic review
Limited — preclinical/traditional/non-oncology human
None
GENERAL / SYSTEMIC
| Symptom | Best match (from the 22) | Rationale | Evidence |
|---|---|---|---|
| Cancer-related fatigue (CRF) | American ginseng (Panax quinquefolius) | Multi-center RCT: improved CRF, greatest benefit on active therapy. | Strong Barton DL et al., J Natl Cancer Inst 2013 |
| CRF during chemotherapy (short-term) | Guaraná (Paullinia cupana) | Randomized trials in breast cancer during chemo show fatigue reduction. | Moderate de Oliveira Campos MP et al., Support Care Cancer 2011 |
| Sleep disturbance | Ashwagandha (Withania somnifera) | Oncology pilot plus broader human data for sleep and QoL. | Moderate Biswal BM et al., Integr Cancer Ther 2013 |
| “Chemo brain” / cognitive fog (supportive) | Rhodiola (R. rosea) | Anti-fatigue and cognitive benefits under stress (adjunct use). | Limited Li Y et al., Chinese Medicine 2017 |
| Flu-like syndromes | Turkey Tail PSP/PSK (Coriolus versicolor) | Immune normalization; improved QoL/infection endpoints with chemo. | Moderate Ma Y et al., Oncotarget 2017 |
| Edema / microcirculation support | Panax notoginseng (Noto ginseng) | Microcirculatory/hemostatic effects (adjunct only). | Limited Clinical hemostasis literature |
| Cachexia / severe debility (adjunct) | Astragalus (A. membranaceus) | TCM adjunct trials with chemo improve tolerance/hematologic recovery. | Moderate Cao A et al., Medicine (Baltimore) 2019 |
| Appetite loss / low intake | Goji (Lycium barbarum) | LBP polysaccharides aid appetite/mood; antioxidant support (non-oncology). | Limited LBP human data |
SKIN / MUCOCUTANEOUS
| Symptom | Best match | Rationale | Evidence |
|---|---|---|---|
| Oral mucositis | Licorice (DGL / aqueous extract) (Glycyrrhiza) | Reduced mucositis severity in RCTs; mucosal film and soothing. | Moderate Najafi S et al., J Dent (Tehran) 2017 |
| Xerostomia / throat irritation | Licorice (DGL) | Mucosal coating; symptom relief. | Limited DGL mucosal support |
| Dry/itchy skin; barrier resilience | Schisandra | Antioxidant/adaptogenic; barrier and oxidative protection. | Limited Hepato/antioxidant reviews |
| Rash (non-emergent) | Reishi | Immune normalization; QoL improvements in small trials. | Limited Jin X et al., Cochrane 2016 |
| Alopecia (cosmetic support) | Fo-Ti (processed) | Traditional hair support; avoid crude root (hepatotoxicity risk). | Limited Safety reviews |
HEMATOLOGIC / IMMUNE
| Symptom | Best match | Rationale | Evidence |
|---|---|---|---|
| Myelosuppression / leukopenia | Astragalus | Adjunct with chemo improves hematologic recovery. | Moderate Systematic reviews/RCTs |
| Neutropenia / infection risk | Turkey Tail PSP/PSK | Immune endpoints improved; used with chemo in East Asia. | Moderate Ma Y 2017; Wang TY 2022 |
| QoL + immune indices | Reishi | Small trials suggest QoL/immune parameter benefits. | Moderate Jin X et al., Cochrane 2016 |
GASTROINTESTINAL
| Symptom | Best match | Rationale | Evidence |
|---|---|---|---|
| Nausea / vomiting (CINV) | — | Use guideline antiemetics; none of these 22 have direct antiemetic RCTs. | None |
| Anorexia | Goji | LBP may support appetite/mood. | Limited LBP human data |
| Esophagitis / odynophagia | Licorice (DGL) | Mucosal film/soothing; extrapolated from oral mucositis data. | Limited–Moderate DGL literature |
| Diarrhea (non-infectious) | Turkey Tail PSP | Microbiome/immune crosstalk; supportive only. | Limited PSP GI data |
| Hepatotoxicity / elevated LFTs | Schisandra ± Baicalin | Hepatoprotective/anti-inflammatory profiles. | Moderate Front Pharmacol 2025 ; Biomed Res Int 2021 |
RESPIRATORY / CARDIO-PULMONARY
| Symptom | Best match | Rationale | Evidence |
|---|---|---|---|
| Cough / airway irritation (supportive) | Reishi | Traditional lung tonic; immune modulation. | Limited Cochrane context |
| Interstitial pneumonitis / fibrosis / effusion / cardiomyopathy / thrombosis | — | Guideline-based medical care required; no herbal substitute in this set. | None |
NEUROLOGICAL / PSYCHOLOGICAL
| Symptom | Best match | Rationale | Evidence |
|---|---|---|---|
| Peripheral neuropathy (supportive) | Ashwagandha | Neurorestorative/anti-inflammatory signals. | Limited Emerging data |
| Cognitive fog / attention | Rhodiola | Anti-fatigue/cognitive support. | Limited Li Y 2017 |
| Anxiety / insomnia | Ashwagandha | Improves sleep/anxiety in small oncology and broader human studies. | Moderate Biswal 2013 |
| Depressed mood / apathy (mild) | Rhodiola or Catuaba | Activating adaptogen or gentle stimulant mood support. | Limited Human data |
MUSCULOSKELETAL / RECOVERY
| Symptom | Best match | Rationale | Evidence |
|---|---|---|---|
| Myalgia / arthralgia (supportive) | Reishi or Ashwagandha | Anti-inflammatory/adaptogenic comfort. | Limited Human data |
| Deconditioning / low work capacity | American ginseng | CRF improvement supports function. | Strong Barton 2013 |
ENDOCRINE / REPRODUCTIVE
| Symptom | Best match | Rationale | Evidence |
|---|---|---|---|
| Low libido / vitality | Maca ± Catuaba | Endocrine/sexual function support (non-oncology human data). | Limited Maca trials |
| Appetite / mood support | Goji | LBP polysaccharides; wellness/QoL signals. | Limited LBP human data |
Formal References (selected)
- Barton DL et al. J Natl Cancer Inst. 2013;105(16):1230–1238.
- de Oliveira Campos MP et al. Support Care Cancer. 2011;19:1089–1096.
- Cao A et al. Medicine (Baltimore). 2019;98:e14729.
- Ma Y et al. Oncotarget. 2017;8:89119–89127.
- Jin X et al. Cochrane Database Syst Rev. 2016:CD007731.
- Najafi S et al. J Dent (Tehran). 2017;14:267–274.
- Huang BH et al. Front Pharmacol. 2025;16:1627081.
- Yang J et al. Biomed Res Int. 2021;2021:4949130.